MedTech Acquisition Corporation Warrant (MTACW)
$0.22
$0.04
(21.11%)
As on 10-Aug-2023 16:00EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
MedTech Acquisition Corporation Warrant (MTACW)
| 190.7 | 118.0 | 235.4 | 327.5 | -- | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout MedTech Acquisition Corporation Warrant (MTACW)
MedTech Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New... York, New York. Read more
-
CEO & Director
Mr. Christopher C. Dewey
-
CEO & Director
Mr. Christopher C. Dewey
-
Headquarters
New York, NY
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for MedTech Acquisition Corporation Warrant (MTACW)
What is the current share price of MedTech Acquisition Corporation Warrant (MTACW) Today?
The share price of MedTech Acquisition Corporation Warrant (MTACW) is $0.22 (NASDAQ) as of 10-Aug-2023 16:00 EDT. MedTech Acquisition Corporation Warrant (MTACW) has given a return of 327.45% in the last 1 years.
What is the current PB & PE ratio of MedTech Acquisition Corporation Warrant (MTACW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
0.42 |
0.36 |
2021 |
3.42 |
0.07 |
2020 |
-- |
-- |
2022 |
0.42 |
0.36 |
2021 |
3.42 |
0.07 |
What is the 52 Week High and Low of MedTech Acquisition Corporation Warrant (MTACW)?
The 52-week high and low of MedTech Acquisition Corporation Warrant (MTACW) are Rs -- and Rs -- as of 05-Sep-2026.
What is the market cap of MedTech Acquisition Corporation Warrant (MTACW)?
MedTech Acquisition Corporation Warrant (MTACW) has a market capitalisation of $ 306 Mln as on 10-Aug-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in MedTech Acquisition Corporation Warrant (MTACW)?
Before investing in MedTech Acquisition Corporation Warrant (MTACW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.